Furthermore, according to our data, the melatonin-mediated reduction of SIRT1 could also affect the MMP2 expression in tumor cells, a zinc-dependent endopeptidase that has been shown to play an important role in extracellular matrix degradation, and thus in prostate tumor progression and tumor migration/invasion [16]. This evidence concerns the gene MMP2 and prostate neoplasm.